Weekly bandage vs. daily cream: dialysis infection prevention showdown
NCT ID NCT05143164
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a special hydrocolloid dressing changed once a week could prevent infections at the catheter exit site in 60 peritoneal dialysis patients, compared to daily antibiotic cream. The goal is to see if the dressing is as good or better at reducing infection rates while being more convenient.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- hydrocolloid dressing (Duoderm Extra Thin) and topical gentamicin cream
- What this could lead to
- If it works, this could offer a simpler, less frequent dressing change option to prevent infections in dialysis patients.
- What could go wrong
- This is a small pilot study with only 60 participants, so results may not be conclusive. The hydrocolloid dressing might not prevent infections as well as daily antibiotic cream.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All adult peritoneal dialysis patients (≥ 21 years old) and are followed up at Singapore General Hospital (SGH) Exclusion Criteria: * Patients who are unable to provide valid consent, patients who have known allergy to hydrocolloid dressing, patients who have peritoneal dialysis catheter exit site infection or peritonitis within the past 3 months, patients who have dialysate leak at PD catheter exit site, pregnant women, patients with life-expectancy of \< 1 year or patients who are currently involved in another study for peritoneal dialysis catheter exit site care.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Peritoneal dialysis catheter exit site infection are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Singapore General Hospital
Singapore, 169856, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.